{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:41:50Z","timestamp":1792633310959,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T00:00:00Z","timestamp":1549411200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s12931-019-0979-0","type":"journal-article","created":{"date-parts":[[2019,2,6]],"date-time":"2019-02-06T09:03:27Z","timestamp":1549443807000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":50,"title":["Porcine vs bovine surfactant therapy for preterm neonates with RDS: systematic review with biological plausibility and pragmatic meta-analysis of respiratory outcomes"],"prefix":"10.1186","volume":"20","author":[{"given":"Ascanio","family":"Tridente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"De Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3846-4834","authenticated-orcid":false,"given":"Daniele","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,6]]},"reference":[{"key":"979_CR1","doi-asserted-by":"publisher","unstructured":"Boghossian NS, Geraci M, Edwards EM, et al. Morbidity and Mortality in Small for Gestational Age Infants at 22 to 29 Weeks' Gestation. Pediatrics. 2018;141(2). \n                    https:\/\/doi.org\/10.1542\/peds.2017-2533\n                    \n                  .","DOI":"10.1542\/peds.2017-2533"},{"key":"979_CR2","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/S0140-6736(53)91451-2","volume":"265","author":"AE Claireaux","year":"1953","unstructured":"Claireaux AE. Hyaline membrane in the neonatal lung. Lancet. 1953;265:749\u201353.","journal-title":"Lancet"},{"key":"979_CR3","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/S2213-2600(17)30214-X","volume":"5","author":"D Luca De","year":"2017","unstructured":"De Luca D, van Kaam AH, Tingay DG, et al. The Montreux definition of neonatal ARDS: biological and clinical background behind the description of a new entity. Lancet Respir Med. 2017;5:657\u201366.","journal-title":"Lancet Respir Med"},{"key":"979_CR4","volume":"6","author":"P Subramaniam","year":"2016","unstructured":"Subramaniam P, Ho JJ, Davis PG. Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants. Cochrane Database Syst Rev. 2016;6:CD001243.","journal-title":"Cochrane Database Syst Rev"},{"key":"979_CR5","volume":"1","author":"AG Paoli De","year":"2008","unstructured":"De Paoli AG, Davis PG, Faber B, et al. Devices and pressure sources for administration of nasal continuous positive airway pressure (NCPAP) in preterm neonates. Cochrane Database Syst Rev. 2008;1:CD002977.","journal-title":"Cochrane Database Syst Rev"},{"key":"979_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1159\/000448985","volume":"111","author":"DG Sweet","year":"2017","unstructured":"Sweet DG, Carnielli V, Greisen G, et al. European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2016 Update. Neonatology. 2017;111:107\u201325.","journal-title":"Neonatology"},{"key":"979_CR7","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1542\/peds.2013-3442","volume":"133","author":"Committee on Fetus and Newborn; American Academy of Pediatrics","year":"2014","unstructured":"Committee on Fetus and Newborn; American Academy of Pediatrics. Respiratory support in preterm infants at birth. Pediatrics. 2014;133:171\u20134.","journal-title":"Pediatrics"},{"key":"979_CR8","volume":"8","author":"S Ardell","year":"2015","unstructured":"Ardell S, Pfister RH, Soll R. Animal derived surfactant extract versus protein free synthetic surfactant for the prevention and treatment of respiratory distress syndrome. Cochrane Database Syst Rev. 2015;8:CD000144.","journal-title":"Cochrane Database Syst Rev"},{"key":"979_CR9","volume":"12","author":"N Singh","year":"2015","unstructured":"Singh N, Halliday HL, Stevens TP, et al. Comparison of animal-derived surfactants for the prevention and treatment of respiratory distress syndrome in preterm infants. Cochrane Database Syst Rev. 2015;12:CD010249.","journal-title":"Cochrane Database Syst Rev"},{"key":"979_CR10","doi-asserted-by":"publisher","first-page":"b2535","DOI":"10.1136\/bmj.b2535","volume":"339","author":"D Moher","year":"2009","unstructured":"Moher D, Liberati A, Tetzlaff J, et al. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. BMJ. 2009;339:b2535.","journal-title":"BMJ"},{"key":"979_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.ejphar.2007.04.035","volume":"568","author":"O Blanco","year":"2007","unstructured":"Blanco O, P\u00e9rez-Gil J. Biochemical and pharmacological differences between preparations of exogenous natural surfactant used to treat respiratory distress syndrome: role of the different components in an efficient pulmonary surfactant. Eur J Pharmacol. 2007;568:1\u201315.","journal-title":"Eur J Pharmacol"},{"key":"979_CR12","first-page":"1725","volume":"2017","author":"M Echaide","year":"1859","unstructured":"Echaide M, Autilio C, Arroyo R, Perez-Gil J. Restoring pulmonary surfactant membranes and films at the respiratory surface. Biochim Biophys Acta. 1859;2017:1725\u201339.","journal-title":"Biochim Biophys Acta"},{"key":"979_CR13","first-page":"771","volume":"40","author":"C Lee","year":"1997","unstructured":"Lee C, Park MS, Kim JN, et al. Physical and biological activity of domestic product of modified bovine lung surfactant. J Korean Pediatr Soc. 1997;40:771\u201385.","journal-title":"J Korean Pediatr Soc"},{"key":"979_CR14","first-page":"3","volume":"69","author":"D Manzanares","year":"1997","unstructured":"Manzanares D, Fern\u00e1ndez R, Moreno O, Torres O, Colom\u00e9 H. Surfacen: Un surfactante natural para el tratamiento del s\u00edndrome del distress respiratorio neonatal. Rev Cuba Pediatr. 1997;69:3\u201310.","journal-title":"Rev Cuba Pediatr"},{"key":"979_CR15","first-page":"1069","volume":"18","author":"M Chang","year":"2016","unstructured":"Chang M, Lu HY, Xiang H, Lan HP. Clinical effects of different ways of mechanical ventilation combined with pulmonary surfactant in treatment of acute lung injury\/acute respiratory distress syndrome in neonates: a comparative analysis. Chin J Contemp Pediatr. 2016;18:1069\u201374.","journal-title":"Chin J Contemp Pediatr"},{"key":"979_CR16","doi-asserted-by":"publisher","first-page":"d5928","DOI":"10.1136\/bmj.d5928","volume":"343","author":"JP Higgins","year":"2011","unstructured":"Higgins JP, Altman DG, G\u00f8tzsche PC, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.","journal-title":"BMJ"},{"key":"979_CR17","doi-asserted-by":"publisher","first-page":"d4002","DOI":"10.1136\/bmj.d4002","volume":"343","author":"JA Sterne","year":"2011","unstructured":"Sterne JA, Sutton AJ, Ioannidis JP, et al. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ. 2011;343:d4002.","journal-title":"BMJ"},{"key":"979_CR18","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1002\/9780470693926.ch11","volume-title":"Systematic reviews in health care: meta-analysis in context. 2nd ed","author":"JAC Sterne","year":"2001","unstructured":"Sterne JAC, Egger M, Davey SG. Investigating and Dealing with Publication and Other Biases. In: Egger M, Davey Smith G, Altman DG, editors. Systematic reviews in health care: meta-analysis in context. 2nd ed. London: BMJ Books; 2001. p. 189\u2013208."},{"key":"979_CR19","volume":"3","author":"D Roberts","year":"2017","unstructured":"Roberts D, Brown J, Medley N, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3:CD004454.","journal-title":"Cochrane Database Syst Rev"},{"key":"979_CR20","doi-asserted-by":"publisher","unstructured":"Dargaville PA, Gerber A, Johansson S, et al. Incidence and Outcome of CPAP Failure in Preterm Infants. Pediatrics. 2016;138(1). \n                    https:\/\/doi.org\/10.1542\/peds.2015-3985\n                    \n                  .","DOI":"10.1542\/peds.2015-3985"},{"key":"979_CR21","doi-asserted-by":"publisher","first-page":"e731","DOI":"10.1542\/peds.2011-0725","volume":"129","author":"H Wang","year":"2012","unstructured":"Wang H, Gao X, Liu C, et al. Morbidity and mortality of neonatal respiratory failure in China: surfactant treatment in very immature infants. Pediatrics. 2012;129:e731\u201340.","journal-title":"Pediatrics"},{"key":"979_CR22","doi-asserted-by":"publisher","first-page":"1559","DOI":"10.1002\/sim.1187","volume":"21","author":"SG Thompson","year":"2002","unstructured":"Thompson SG, Higgins JP. How should meta-regression analyses be undertaken and interpreted? Stat Med. 2002;21:1559\u201373.","journal-title":"Stat Med"},{"key":"979_CR23","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/1471-2288-9-80","volume":"9","author":"BC Wallace","year":"2009","unstructured":"Wallace BC, Schmid CH, Lau J, et al. Meta-analyst: software for meta-analysis of binary, continuous and diagnostic data. BMC Med Res Methodol. 2009;9:80.","journal-title":"BMC Med Res Methodol"},{"key":"979_CR24","unstructured":"Van Rhee HJ, Suurmond R, Hak T. User manual for Meta-Essentials: Workbooks for meta-analysis (Version 1.0) Rotterdam, The Netherlands: Erasmus Research Institute of Management. \n                    www.erim.eur.nl\/research-support\/meta-essentials\n                    \n                  . Accessed 8 Sept 2017."},{"key":"979_CR25","first-page":"7","volume":"4","author":"R Saeidi","year":"2013","unstructured":"Saeidi R, Hamedi A, Javadi A, et al. Comparison of side effect of survanta and curosurf in decreasing mortality due to respiratory distress syndrome (RDS) in premature infants admitted in NICU of Ghaem Hospital On 2006-2008. Ir J Neonatol. 2013;4:7\u201312.","journal-title":"Ir J Neonatol"},{"key":"979_CR26","first-page":"644","volume":"68","author":"R Saeidi","year":"2011","unstructured":"Saeidi R, Hamedi A, Javadi A, et al. Comparing effects of beractant and poractant alfa in decreasing mortality rate due to respiratory distress syndrome in premature infants. Tehran Univ Med J. 2011;68:644\u20138.","journal-title":"Tehran Univ Med J"},{"key":"979_CR27","first-page":"1071","volume":"43","author":"S Akar","year":"2015","unstructured":"Akar S, \u00d6zalkaya E. Comparison of efficacy of beractant and poractant treatment performed with minimal invasive technique. J Perinat Med. 2015;43:1071 [abstract].","journal-title":"J Perinat Med"},{"key":"979_CR28","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s00431-002-1144-0","volume":"162","author":"G Baroutis","year":"2003","unstructured":"Baroutis G, Kaleyias J, Liarou T, et al. Comparison of three treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Eur J Pediatr. 2003;162:476\u201380.","journal-title":"Eur J Pediatr"},{"key":"979_CR29","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1055\/s-0031-1295648","volume":"29","author":"EA Dizdar","year":"2012","unstructured":"Dizdar EA, Sari FN, Aydemir C, et al. A randomized, controlled trial of poractant alfa versus beractant in the treatment of preterm infants with respiratory distress syndrome. Am J Perinatol. 2012;29:95\u2013100.","journal-title":"Am J Perinatol"},{"key":"979_CR30","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/jp.2010.20","volume":"30","author":"AM Fujii","year":"2010","unstructured":"Fujii AM, Patel SM, Allen R, et al. Poractant alfa and beractant treatment of very premature infants with respiratory distress syndrome. J Perinatol. 2010;30:665\u201370.","journal-title":"J Perinatol"},{"key":"979_CR31","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1007\/s12098-010-0097-y","volume":"77","author":"MM Gharehbaghi","year":"2010","unstructured":"Gharehbaghi MM, Sakha SH, Ghojazadeh M, et al. Complications among premature neonates treated with beractant and poractant alfa. Indian J Pediatr. 2010;77:751\u20134.","journal-title":"Indian J Pediatr"},{"key":"979_CR32","doi-asserted-by":"publisher","first-page":"245","DOI":"10.15296\/ijwhr.2014.36","volume":"2","author":"MM Gharehbaghi","year":"2014","unstructured":"Gharehbaghi MM, Yasrebi S. Comparing the Efficacy of two Natural Surfactants, Curosurf and Alveofact, in Treatment of Respiratory Distress Syndrome in Preterm Infants. Int J Women Health Reprod Sci. 2014;2:245\u20138.","journal-title":"Int J Women Health Reprod Sci"},{"key":"979_CR33","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1055\/s-0034-1370344","volume":"31","author":"N Karadag","year":"2014","unstructured":"Karadag N, Dilli D, Zenciroglu A, et al. Perfusion index variability in preterm infants treated with two different natural surfactants for respiratory distress syndrome. Am J Perinatol. 2014;31:1015\u201322.","journal-title":"Am J Perinatol"},{"key":"979_CR34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0175922","volume":"12","author":"B Lemyre","year":"2017","unstructured":"Lemyre B, Fusch C, Schm\u00f6lzer GM, et al. Poractant alfa versus bovine lipid extract surfactant for infants 24+0 to 31+6 weeks gestational age: a randomized controlled trial. PLoS One. 2017;12:e0175922.","journal-title":"PLoS One"},{"key":"979_CR35","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1080\/08035250510028740","volume":"94","author":"CA Malloy","year":"2005","unstructured":"Malloy CA, Nicoski P, Muraskas JK. A randomized trial comparing beractant and poractant treatment in neonatal respiratory distress syndrome. Acta Paediatr. 2005;94:779\u201384.","journal-title":"Acta Paediatr"},{"key":"979_CR36","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1007\/s12325-010-0044-3","volume":"27","author":"VV Mercado","year":"2010","unstructured":"Mercado VV, Cristea I, Ali N, et al. Does surfactant type cause a differential proinflammatory response in preterm infants with respiratory distress syndrome? Adv Ther. 2010;27:476\u201382.","journal-title":"Adv Ther"},{"key":"979_CR37","volume":"26","author":"M Mussavi","year":"2016","unstructured":"Mussavi M, Mirnia K, Asadollahi K. Comparison of the efficacy of three natural surfactants (Curosurf, Survanta, and Alveofact) in the treatment of respiratory distress syndrome among neonates: a randomized controlled trial. Iran J Pediatr. 2016;26:e5743.","journal-title":"Iran J Pediatr"},{"key":"979_CR38","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.conctc.2016.04.003","volume":"3","author":"B Najafian","year":"2016","unstructured":"Najafian B, Karimi-Sari H, Hossein Khosravi M, et al. Comparison of efficacy and safety of two available natural surfactants in Iran, Curosurf and Survanta in treatment of neonatal respiratory distress syndrome: a randomized clinical trial. Contemp Clin Trials Commun. 2016;3:55\u20139.","journal-title":"Contemp Clin Trials Commun"},{"key":"979_CR39","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1055\/s-2004-823779","volume":"21","author":"R Ramanathan","year":"2004","unstructured":"Ramanathan R, Rasmussen MR, Gerstmann DR, et al. A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants. Am J Perinatol. 2004;21:109\u201319.","journal-title":"Am J Perinatol"},{"key":"979_CR40","doi-asserted-by":"publisher","first-page":"F8","DOI":"10.1136\/fn.72.1.F8","volume":"72","author":"CP Speer","year":"1995","unstructured":"Speer CP, Gefeller O, Groneck P, et al. Randomised clinical trial of two treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed. 1995;72:F8\u201313.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"979_CR41","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.pedneo.2014.11.004","volume":"56","author":"D Terek","year":"2015","unstructured":"Terek D, Gonulal D, Koroglu OA, et al. Effects of Two Different Exogenous Surfactant Preparations on Serial Peripheral Perfusion Index and Tissue Carbon Monoxide Measurements in Preterm Infants with Severe Respiratory Distress Syndrome. Pediatr Neonatol. 2015;56:248\u201355.","journal-title":"Pediatr Neonatol"},{"key":"979_CR42","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1590\/S1679-45082014AO3095","volume":"12","author":"CM Rebello","year":"2014","unstructured":"Rebello CM, Precioso AR, Mascaretti RS, Grupo Colaborativo do Estudo Brasileiro Multic\u00eantrico de Surfactante. A multicenter, randomized, double-blind trial of a new porcine surfactant in premature infants with respiratory distress syndrome. Einstein (Sao Paulo). 2014;12:397\u2013404.","journal-title":"Einstein (Sao Paulo)"},{"key":"979_CR43","first-page":"267","volume":"4","author":"M S\u00e1nchez-Mendiola","year":"2005","unstructured":"S\u00e1nchez-Mendiola M, Mart\u00ednez-Nater OC, Herrera-Maldonado N, et al. Estudio controlado del tratamiento de la enfermedad de membrana hialina del reci\u00e9n nacido pret\u00e9rmino con surfactante pulmonar ex\u00f3geno (porcino vs. bovino). Gac M\u00e9d M\u00e9x. 2005;4:267\u201371 [article in Spanish].","journal-title":"Gac M\u00e9d M\u00e9x"},{"key":"979_CR44","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s00431-003-1366-9","volume":"163","author":"RA Shalwitz","year":"2004","unstructured":"Shalwitz RA. Comparison of treatment regimens of natural surfactant preparations in neonatal respiratory distress syndrome. Eur J Pediatr. 2004;163:126.","journal-title":"Eur J Pediatr"},{"key":"979_CR45","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/jp.2010.88","volume":"30","author":"D Lutchman","year":"2010","unstructured":"Lutchman D. Have we been down this road before? J Perinatol. 2010;30:698\u20139.","journal-title":"J Perinatol"},{"key":"979_CR46","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1055\/s-2004-829876","volume":"21","author":"E Bancalari","year":"2004","unstructured":"Bancalari E. On \"A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants\" (Am J Perinatol 2004;21:109-120). Am J Perinatol. 2004;21:307\u20139.","journal-title":"Am J Perinatol"},{"key":"979_CR47","doi-asserted-by":"publisher","first-page":"F121","DOI":"10.1136\/fn.73.2.F121","volume":"73","author":"S Logan","year":"1995","unstructured":"Logan S. Need to avoid bias in controlled trials. Arch Dis Child Fetal Neonatal Ed. 1995;73:F121.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"979_CR48","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.pedneo.2015.03.004","volume":"56","author":"MJ Jeng","year":"2015","unstructured":"Jeng MJ. Effects of two different exogenous surfactant preparations on serial peripheral perfusion index and tissue carbon monoxide measurements in preterm infants with severe respiratory distress syndrome. Pediatr Neonatol. 2015;56:211\u20132.","journal-title":"Pediatr Neonatol"},{"key":"979_CR49","doi-asserted-by":"publisher","first-page":"e1588","DOI":"10.1542\/peds.2011-1395","volume":"128","author":"N Singh","year":"2011","unstructured":"Singh N, Hawley KL, Viswanathan K. Efficacy of porcine versus bovine surfactants for preterm newborns with respiratory distress syndrome: systematic review and meta-analysis. Pediatrics. 2011;128:e1588\u201395.","journal-title":"Pediatrics"},{"key":"979_CR50","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.pupt.2015.08.005","volume":"34","author":"L Zhang","year":"2015","unstructured":"Zhang L, Cao HY, Zhao S, et al. Effect of exogenous pulmonary surfactants on mortality rate in neonatal respiratory distress syndrome: a network meta-analysis of randomized controlled trials. Pulm Pharmacol Ther. 2015;34:46\u201354.","journal-title":"Pulm Pharmacol Ther"},{"key":"979_CR51","first-page":"78","volume":"8","author":"B Holm","year":"2008","unstructured":"Holm B, Cummings JJ. Is there evidence for a mortality difference between exogenous surfactant preparations in neonatal RDS? J Appl Res. 2008;8:78\u201383.","journal-title":"J Appl Res"},{"key":"979_CR52","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/j.jpeds.2010.05.043","volume":"157","author":"AH Kaam van","year":"2010","unstructured":"van Kaam AH, Rimensberger PC, Borensztajn D, et al. Ventilation practices in the neonatal intensive care unit: a cross-sectional study. J Pediatr. 2010;157:767\u201371.","journal-title":"J Pediatr"},{"key":"979_CR53","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jpeds.2009.07.044","volume":"156","author":"JV Been","year":"2010","unstructured":"Been JV, Rours IG, Kornelisse RF, et al. Chorioamnionitis alters the response to surfactant in preterm infants. J Pediatr. 2010;156:10\u20135.","journal-title":"J Pediatr"},{"key":"979_CR54","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1007\/s00134-008-1224-3","volume":"34","author":"D Luca De","year":"2008","unstructured":"De Luca D, Baroni S, Vento G, et al. Secretory phospholipase A2 and neonatal respiratory distress: pilot study on broncho-alveolar lavage. Intensive Care Med. 2008;34:1858\u201364.","journal-title":"Intensive Care Med"},{"key":"979_CR55","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1164\/ajrccm.163.1.2005029","volume":"163","author":"P Cavicchioli","year":"2001","unstructured":"Cavicchioli P, Zimmermann LJ, Cogo PE, et al. Endogenous surfactant turnover in preterm infants with respiratory distress syndrome studied with stable isotope lipids. Am J Respir Crit Care Med. 2001;163:55\u201360.","journal-title":"Am J Respir Crit Care Med"},{"key":"979_CR56","doi-asserted-by":"publisher","first-page":"3383","DOI":"10.1097\/00003246-200010000-00001","volume":"28","author":"JE Bunt","year":"2000","unstructured":"Bunt JE, Carnielli VP, Janssen DJ, et al. Treatment with exogenous surfactant stimulates endogenous surfactant synthesis in premature infants with respiratory distress syndrome. Crit Care Med. 2000;28:3383\u20138.","journal-title":"Crit Care Med"},{"key":"979_CR57","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jama.284.1.43","volume":"284","author":"VM Ranieri","year":"2000","unstructured":"Ranieri VM, Giunta F, Suter PM, et al. Mechanical ventilation as a mediator of multisystem organ failure in acute respiratory distress syndrome. JAMA. 2000;284:43\u20134.","journal-title":"JAMA"},{"key":"979_CR58","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1164\/ajrccm.159.2.9805053","volume":"159","author":"A Berger","year":"1999","unstructured":"Berger A, Havet N, Vial D, et al. Dioleylphosphatidylglycerol inhibits the expression of type II phospholipase A2 in macrophages. Am J Respir Crit Care Med. 1999;159:613\u20138.","journal-title":"Am J Respir Crit Care Med"},{"key":"979_CR59","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/pr.2014.176","volume":"77","author":"O Danhaive","year":"2015","unstructured":"Danhaive O, Chapin C, Horneman H, et al. Surface film formation in vitro by infant and therapeutic surfactants: role of surfactant protein B. Pediatr Res. 2015;77:340\u20136.","journal-title":"Pediatr Res"},{"key":"979_CR60","doi-asserted-by":"publisher","first-page":"L257","DOI":"10.1152\/ajplung.00054.2011","volume":"302","author":"RD Hite","year":"2012","unstructured":"Hite RD, Grier BL, Waite BM, et al. Surfactant protein B inhibits secretory phospholipase A2 hydrolysis of surfactant phospholipids. Am J Physiol Lung Cell Mol Physiol. 2012;302:L257\u201365.","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"979_CR61","doi-asserted-by":"publisher","first-page":"e950","DOI":"10.1542\/peds.2009-0126","volume":"124","author":"PE Cogo","year":"2009","unstructured":"Cogo PE, Facco M, Simonato M, et al. Dosing of porcine surfactant: effect on kinetics and gas exchange in respiratory distress syndrome. Pediatrics. 2009;124:e950\u20137.","journal-title":"Pediatrics"},{"key":"979_CR62","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1007\/s00134-010-2091-2","volume":"37","author":"PE Cogo","year":"2011","unstructured":"Cogo PE, Facco M, Simonato M, et al. Pharmacokinetics and clinical predictors of surfactant redosing in respiratory distress syndrome. Intensive Care Med. 2011;37:510\u20137.","journal-title":"Intensive Care Med"},{"key":"979_CR63","first-page":"632","volume":"2009","author":"KW Lu","year":"1788","unstructured":"Lu KW, P\u00e9rez-Gil J, Taeusch H. Kinematic viscosity of therapeutic pulmonary surfactants with added polymers. Biochim Biophys Acta. 1788;2009:632\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"979_CR64","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1159\/000322004","volume":"100","author":"AH Kaam van","year":"2011","unstructured":"van Kaam AH, De Jaegere AP, Borensztajn D, et al. Surfactant replacement therapy in preterm infants: a European survey. Neonatology. 2011;100:71\u20137.","journal-title":"Neonatology"},{"key":"979_CR65","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1111\/apa.13672","volume":"106","author":"D Hines","year":"2017","unstructured":"Hines D, Modi N, Lee SK, et al. Scoping review shows wide variation in the definitions of bronchopulmonary dysplasia in preterm infants and calls for a consensus. Acta Paediatr. 2017;106:366\u201374.","journal-title":"Acta Paediatr"},{"key":"979_CR66","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1159\/000369878","volume":"107","author":"RB Parad","year":"2015","unstructured":"Parad RB, Davis JM, Lo J, et al. Prediction of respiratory outcome in extremely low gestational age infants. Neonatology. 2015;107:241\u20138.","journal-title":"Neonatology"},{"key":"979_CR67","doi-asserted-by":"publisher","first-page":"186","DOI":"10.3389\/fped.2017.00186","volume":"5","author":"F Ricci","year":"2017","unstructured":"Ricci F, Salomone F, Kuypers E, Ophelders D, Nikiforou M, Willems M, Krieger T, Murgia X, H\u00fctten M, Kramer BW, Bianco F. In Vivo Evaluation of the Acute Pulmonary Response to Poractant Alfa and Bovactant Treatments in Lung-Lavaged Adult Rabbits and in Preterm Lambs with Respiratory Distress Syndrome. Front Pediatr. 2017;5:186. \n                    https:\/\/doi.org\/10.3389\/fped.2017.00186\n                    \n                  .","journal-title":"Front Pediatr"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-0979-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12931-019-0979-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-019-0979-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T19:09:10Z","timestamp":1580929750000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-019-0979-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,6]]},"references-count":67,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["979"],"URL":"https:\/\/doi.org\/10.1186\/s12931-019-0979-0","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,6]]},"assertion":[{"value":"22 October 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable as this is a review and meta-analysis. Trials meta-analysed have all received their original ethical approval.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"A\/Prof. D. De Luca has received grants for research and educational projects from Chiesi Pharmaceuticals spa and ABBVIE inc. He also received travel grants from ABBVIE inc. He served as consultant and lecturer for both Chiesi Pharmaceuticals spa and ABBVIE inc. Finally, he has been member of the external advisory board for both Chiesi Pharmaceuticals spa and ABBVIE inc. These companies produce two surfactants analysed in the paper, but they had no role in design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, approval of the manuscript or decision to submit it for publication. The other authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"28"}}